10,11-methylenedioxycamptothecin

structure in first source

Also Known As:

MDCPT cpd

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Carcinoma (Carcinomatosis) 08/01/1991 - "S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methylenedioxycamptothecin in human colon carcinoma HT-29 cells." 01/01/1990 - "10,11-Methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cells."
2.	Keloid 11/04/2014 - "Transdermal delivery of 10,11-methylenedioxycamptothecin by hyaluronic acid based nanoemulsion for inhibition of keloid fibroblast."